Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92,219Revenue $M19,620Net Margin (%)10.5Altman Z-Score4.1
Enterprise Value $M96,023EPS $1.9Operating Margin %15.9Piotroski F-Score4
P/E(ttm)43.1Beneish M-Score-2.6Pre-tax Margin (%)12.6Higher ROA y-yN
Price/Book6.310-y EBITDA Growth Rate %10.8Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %-6.0Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow41.6y-y EBITDA Growth Rate %-30.1ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %2.4PEG--ROE % (ttm)12.8Less Shares Outstanding y-yY
Payout Ratio %103Shares Outstanding M1,109ROIC % (ttm)14.1Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYCharles Brandes 2015-06-30 Sold Out -0.11%$70.89 - $86.59
($76.14)
$ 83.199%Sold Out0
LLYVanguard Health Care Fund 2015-06-30 Add0.08%$70.89 - $86.59
($76.14)
$ 83.199%Add 1.94%25,375,160
LLYKen Fisher 2015-06-30 Add0.04%$70.89 - $86.59
($76.14)
$ 83.199%Add 29.29%1,029,030
LLYHOTCHKIS & WILEY 2015-06-30 Reduce-0.03%$70.89 - $86.59
($76.14)
$ 83.199%Reduce 2.52%3,868,109
LLYDodge & Cox 2015-06-30 Reduce$70.89 - $86.59
($76.14)
$ 83.199%Reduce 9.94%32,634
LLYMario Gabelli 2015-06-30 Reduce$70.89 - $86.59
($76.14)
$ 83.199%Reduce 12.43%97,900
LLYVanguard Health Care Fund 2015-03-31 Add0.45%$68.41 - $76.36
($71.19)
$ 83.1917%Add 13.24%24,892,160
LLYCharles Brandes 2015-03-31 Reduce-0.06%$68.41 - $76.36
($71.19)
$ 83.1917%Reduce 36.80%107,025
LLYKen Fisher 2015-03-31 Add0.03%$68.41 - $76.36
($71.19)
$ 83.1917%Add 37.46%795,909
LLYHOTCHKIS & WILEY 2015-03-31 Add0.01%$68.41 - $76.36
($71.19)
$ 83.1917%Add 0.70%3,968,039
LLYJoel Greenblatt 2015-03-31 Sold Out -0.0031%$68.41 - $76.36
($71.19)
$ 83.1917%Sold Out0
LLYDodge & Cox 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 83.1917%Reduce 7.10%36,234
LLYMario Gabelli 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 83.1917%Reduce 1.76%111,800
LLYCharles Brandes 2014-12-31 Reduce-1.85%$61.9 - $72.83
($67.53)
$ 83.1923%Reduce 92.65%169,348
LLYRichard Pzena 2014-12-31 Sold Out -0.15%$61.9 - $72.83
($67.53)
$ 83.1923%Sold Out0
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 83.1923%Add 383.26%578,992
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 83.1931%Reduce 14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 83.1931%Reduce 10.92%4,321,666
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 83.1931%Sold Out0
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 83.1931%Reduce 84.40%900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mahony SusanSVP & Pres., Lilly Oncology 2015-07-28Sell25,000$84.96-2.08view
LILLY ENDOWMENT INC10% Owner 2015-06-10Sell210,000$82.390.97view
LILLY ENDOWMENT INC10% Owner 2015-06-04Sell200,000$77.96.79view
Simmons Jeffrey NSVP&Pres. Elanco Animal Health 2015-05-29Sell20,000$78.086.54view
Zakrowski Donald AChief Accounting Officer 2015-05-29Sell200$78.336.2view
LILLY ENDOWMENT INC10% Owner 2015-05-20Sell190,000$73.4313.29view
LILLY ENDOWMENT INC10% Owner 2015-05-15Sell200,000$72.8314.22view
LILLY ENDOWMENT INC10% Owner 2015-05-08Sell195,000$73.2813.52view
LILLY ENDOWMENT INC10% Owner 2015-05-01Sell200,000$73.0913.82view
LILLY ENDOWMENT INC10% Owner 2015-03-30Sell180,000$73.9412.51view

Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    John Hussman Buys, Sells Most Valuable Stakes in Second Quarter Aug 04 2015 
    Weekly 52-Week Highs Highlight: LLY, PLL, SBUX, VLO Jul 07 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 
    What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
    Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
    Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 

    More From Other Websites
    FDA Says Certain Type 2 Diabetes Drugs Can Cause Serious Joint Pain Aug 28 2015
    PRIMECAP Sells Stake in Biopharmaceutical Company Aug 28 2015
    Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval Aug 28 2015
    Credit Suisse's 8 Pharmaceutical Stocks With 'Significant' Upside Aug 28 2015
    Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock? Aug 28 2015
    Experimental Lilly Lung-Cancer Drug Stirs Price Debate Aug 27 2015
    Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled Aug 27 2015
    Lilly to Participate in Morgan Stanley Global Healthcare Conference Aug 27 2015
    Lilly to Participate in Morgan Stanley Global Healthcare Conference Aug 27 2015
    U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2... Aug 27 2015
    Coverage initiated on Eli Lilly by Berenberg Aug 27 2015
    2:55 am Eli Lilly and Adocia initiate Phase 1b clinical trial evaluating BioChaperone Lispro Aug 27 2015
    Adocia and Lilly initiate new Phase 1b study of repeated administration of ultra-rapid BioChaperone... Aug 27 2015
    Eli Lilly's Alimta Patent Upheld by U.S. District Court Aug 26 2015
    2Q15 Performance of AstraZeneca’s ING Segment Aug 26 2015
    Lilly Says Court Ruled in its Favor on Patent Aug 25 2015
    U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent Aug 25 2015
    U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent Aug 25 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK